Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Bridging brain insulin resistance to Alzheimer’s pathogenesis

Trends in Biochemical Sciences(2024)10.1016/j.tibs.2024.09.004Source: DataRank Database

Bridging brain insulin resistance to Alzheimer’s pathogenesis is a research paper published in Trends in Biochemical Sciences (2024). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

10 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 1.59)OA: closedTopics (49)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Valdemar Brimnes Ingemann Johansen ORCID,Cristina Legido‐Quigley ORCID,Wenqiang Chen ORCID

Live enrichment

PubMed:39358050 OpenAlex:https://openalex.org/W4403047023

Novo Nordisk Foundation

Grant: NNF23OC0087108

Lundbeck Foundation

Grant: R344-2020-989

National Institute of Diabetes and Digestive and Kidney Diseases Division of Diabetes Endocrinology and Metabolic Diseases

Grant: DK007260

NIDA NIH HHS

Grant: T32 DA007260

NNF Center for Basic Metabolic Research

Grant: Clemmensen Group

Novo Nordisk Foundation

Grant: unidentified

unidentified

National Institutes of Health

FWCI

1.59

Citation Percentile

0.8%

Citation Trend

2025

2026

closedLicense: Elsevier TDM

publisherhttps://api.elsevier.com/content/article/PII:S0968000424002093?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0968000424002093?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.tibs.2024.09.004

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39358050

repositoryhttps://researchprofiles.ku.dk/da/publications/47ae541b-a8c6-4c4a-8fc3-ee72f26d154c

Fields of Study

Mitochondrial Function and PathologyLiver Disease Diagnosis and TreatmentMetabolism and Genetic Disorders03 medical and health sciences0302 clinical medicine

MeSH Terms

Glycogen Synthase Kinase 3 betaAlzheimer DiseaseAnimalsBrainDiabetes Mellitus, Type 2HumansInsulin ResistanceMitochondriaPhosphorylationGlycogen Synthase Kinase 3Oxidoreductases Acting on CH-CH Group Donors

Keywords

Insulin resistanceType 2 Diabetes MellitusGSK-3Glycogen synthasePathogenesisBiliverdin reductaseInsulinEndocrinologyDiabetes mellitusAlzheimer's diseaseInsulin receptorInternal medicinePhosphorylationBiologyDiseaseMedicineNeuroscienceCell biologyEnzymeBiochemistryHemeMitochondriaCognitionNeurodegenerationBiliverdin Reductase-a (Bvr-a)Oxidoreductases Acting on CH-CH Group DonorsGlycogen Synthase Kinase 3 betaBrainGlycogen Synthase Kinase 3Diabetes Mellitus, Type 2Alzheimer DiseaseHumansAnimals

Sustainable Development Goals

SDG 0: Zero hunger

Bridging brain insulin resistance to Alzheimer’s pathogenesis

FAIR Checklist

Authors (3)

Funding (7 grants)

Impact

Open Access

Topics